These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 1577406

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. beta 2-Microglobulin in Paget's bone disease.
    Rico H, Ripoll E, Arribas I, Revilla M, Relea P, Villa LF, de Buergo MA.
    Calcif Tissue Int; 1994 May; 54(5):389-91. PubMed ID: 8062156
    [Abstract] [Full Text] [Related]

  • 4. Serum osteocalcin concentrations in Paget's disease of bone.
    Wilkinson MR, Wagstaffe C, Delbridge L, Wiseman J, Posen S.
    Arch Intern Med; 1986 Feb; 146(2):268-71. PubMed ID: 3484940
    [Abstract] [Full Text] [Related]

  • 5. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.
    Meier C, Meinhardt U, Greenfield JR, De Winter J, Nguyen TV, Dunstan CR, Seibel MJ.
    Clin Lab; 2006 Feb; 52(1-2):1-10. PubMed ID: 16506358
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Paget's disease of bone: presentation, extent and response to bisphosphonates.
    Wang LM, Au-Yeong ML, McKenna MJ.
    Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Paget's disease of bone in a patient on hemodialysis.
    Etemadi J, Bagheri N, Falaknazi K, Ardalan M, Rahbar K, Nobakht Haghighi A, Mohajel Shoja M.
    Iran J Kidney Dis; 2008 Apr; 2(2):105-7. PubMed ID: 19377219
    [Abstract] [Full Text] [Related]

  • 10. Bone alkaline phosphatase in Paget's disease.
    Deftos LJ, Wolfert RL, Hill CS.
    Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067
    [Abstract] [Full Text] [Related]

  • 11. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD, Gutteridge DH, Prince RL, Retallack RW, Worth GK.
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [Abstract] [Full Text] [Related]

  • 12. Inflammatory cytokines in Paget's disease of bone.
    Werner de Castro GR, Buss Z, Da Rosa JS, Fröde TS.
    Int Immunopharmacol; 2014 Feb; 18(2):277-81. PubMed ID: 24355795
    [Abstract] [Full Text] [Related]

  • 13. Increased circulating Dickkopf-1 in Paget's disease of bone.
    Marshall MJ, Evans SF, Sharp CA, Powell DE, McCarthy HS, Davie MW.
    Clin Biochem; 2009 Jul; 42(10-11):965-9. PubMed ID: 19389391
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L, Peris P, Guañabens N, Vidal S, Quintó L, Monegal A, Pons F, Ballesta AM, Muñoz-Gómez J.
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Paget's disease of bone with intravenous pamidronate: comparison of 2 different modes of treatment.
    Ismail AA, Fox P, Stamp TC, Dhillon V, Crisp AJ, MacGregor A.
    J Rheumatol; 1997 Nov; 24(11):2266-7. PubMed ID: 9375899
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A, Mermillod B, Schenk R, Courvoisier B, Burkhardt P, Epiney J, Fleisch.
    Schweiz Med Wochenschr; 1976 Nov 27; 106(48):1667-73. PubMed ID: 827810
    [Abstract] [Full Text] [Related]

  • 18. Newer agents in treating Paget's disease of bone.
    Goldfield EB.
    Geriatrics; 1974 Dec 27; 29(12):61-9. PubMed ID: 4279196
    [No Abstract] [Full Text] [Related]

  • 19. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD.
    Arthritis Rheum; 1998 Feb 27; 41(2):354-60. PubMed ID: 9485094
    [Abstract] [Full Text] [Related]

  • 20. Effects of five daily 1 h infusions of alendronate in Paget's disease of bone.
    O'Doherty DP, Gertz BJ, Tindale W, Sciberras DG, Survill TT, Kanis JA.
    J Bone Miner Res; 1992 Jan 27; 7(1):81-7. PubMed ID: 1549961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.